In-vitro testing of the drug cytostasan in malignant gynecologic tumors
Marzotko, F.; Krafft, W.; Preibsch, W.; Schröder, M.
Das Deutsche Gesundheitswesen 28(2): 87-88
1973
ISSN/ISBN: 0012-0219 PMID: 4724672 Document Number: 62823
Document emailed within 1 workday
Related Documents
Sun, D.; Yu, L.X.; Hussain, M.A.; Wall, D.A.; Smith, R.L.; Amidon, G.L. 2004: In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome Current Opinion in Drug Discovery and Development 7(1): 75-85Inoue, S.; Shibata, S.; Okumura, A.; Tanaka, T.; Onitsuka, Y.; Yoshimura, T.; Aiko, A.; Ikuta, Y.; Fukuma, K.; Matsuura, K. 1985: UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(3 Part 1): 499-504
Zhang, G.N. 1993: Preliminary trials of immune function of erythrocytes in women with benign or malignant gynecologic tumors Zhonghua Fu Chan Ke Za Zhi 28(2): 88-90; 123
Volm, M.; Ehrhart, H. 1977: Resistance testing of malignant tumors Münchener Medizinische Wochenschrift 119(9 Suppl): 7-8
Carter, J.; Saltzman, A.; Hartenbach, E.; Fowler, J.; Carson, L.; Twiggs, L.B. 1994: Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler Obstetrics and Gynecology 83(1): 125-130
Král, V.; Hajdúch, M.; Neoral, C.; Klein, J.; Mihál, V.; Orel, M.; Aujeský, R.; Vyslouzil, K.; Cwiertka, K.; Kolek, V.; Nosková, V. 2000: Significance and possibilities of cytostatic treatment of malignant tumors: testing the effects of cytostatics Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 79(3): 134-138
Urwyler, A.; Censier, K.; Seeberger, M.D.; Drewe, J.; Rothenbühler, J.M.; Frei, F. 1991: Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland Schweizerische Medizinische Wochenschrift 121(16): 566-571
Shah, D.R.; Hoeksema, J.; Korbet, S.M. 2000: Von Hippel-Lindau disease with multiple malignant renal tumors: the importance of genetic testing Clinical Nephrology 53(3): 216-221
Chekharina, E.A. 1982: Errors in the drug therapy of malignant tumors Meditsinskaia Sestra 41(10): 25-27
Von Hoff, D.D. 1985: Implications of tumor cell heterogeneity for in vitro drug sensitivity testing Seminars in Oncology 12(3): 327-331
Druilhe, P.; Mazier, D.; Brandicourt, O.; Gentilini, M. 1983: One-step Plasmodium falciparum cultivation--application to in-vitro drug testing Tropenmedizin und Parasitologie 34(4): 233-234
Nomura, K.; Nagane, M.; Shibui, S. 1992: Chemo-sensitivity test for malignant brain tumors by DNA histogram, in vitro Nihon Rinsho. Japanese Journal of Clinical Medicine 50(10): 2374-2380
Vtorushin, S.V.; Khristenko, K.Y.; Zavyalova, M.V.; Perelmuter, V.M.; Litviakov, N.V.; Denisov, E.V.; Dulesova, A.Y.; Cherdyntseva, N.V. 2014: The phenomenon of multi-drug resistance in the treatment of malignant tumors Experimental Oncology 36(3): 144-156
Elprana, D.; Schwachöfer, J.; Kuijpers, W.; Van Den Broek, P.; Wagener, D.J. 1989: Cytotoxic drug sensitivity of squamous cell carcinoma as predicted by an in vitro testing model Anticancer Research 9(4): 1089-1094
Rob, L.; Svoboda, B.; Robová, H.; Stankusová, H.; Cwiertka, K.; Neumannová, R.; Petera, J.; Koliba, P.; Kudela, M. 2004: Guideline for gynecological malignant tumors--primary complex therapy in operable stages of malignant tumors of uterus cervix Ceska Gynekologie 69(5): 376-383
Durando, C. 1984: Current possibilities of the timely diagnosis, preoperative staging and prevention of malignant tumors of the ovary. A) Diagnostic problem of malignant ovarian tumors Minerva Ginecologica 36(4): 143-144
Florio, T.; Montella, L.; Corsaro, A.; De Chiara, A.; Apice, G.; Fazioli, F.; Lastoria, S.; Schettini, G.; Palmieri, G. 2003: In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumors Anticancer Research 23(3b): 2465-2471
Wang, Q.L. 1989: Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors Zhonghua Zhong Liu Za Zhi 11(3): 222-225
Ness, R.B.; Wisniewski, S.R.; Eng, H.; Christopherson, W. 2002: Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical response Anticancer Research 22(2b): 1145-1149
Kashani-Sabet, M.; Rossi, J.J.; Lu, Y.; Ma, J.X.; Chen, J.; Miyachi, H.; Scanlon, K.J. 1988: Detection of drug resistance in human tumors by in vitro enzymatic amplification Cancer Research 48(20): 5775-5778